ChatAbout Dr. Burhan Ferhanoglu
- Dr. Burhan Ferhanoğlu is a hematologist with 40+ years of experience.
- He is a member of the Turkish Society of Hematology, International Society of Hematology, European Hematology Association, American Society of Hematology and European Bone Marrow Transplantation Society.
- He graduated from Istanbul University, Istanbul in 1978, completed his residency in internal medicine from Istanbul University, Istanbul in 1982 and fellowship in hematology from Istanbul University, Istanbul in 1988.
- Dr. Burhan has conducted studies at the department of hematology and oncology at the University of Texas in 1990 and 1991.
- He made investigations at the Bone Marrow Transplantation Unit of Fred Hutchinson Cancer Research Center, Seattle in 1992.
- He has bagged many awards due to his contribution in the medical field.
Hospital
American Hospital, Istanbul Location
Istanbul, Turkey 
LocationSpecial Interest
Bone marrow transplant, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myeloma, Myelodysplastic syndromes
Work Experience of Dr. Burhan Ferhanoglu
Dr. Burhan Ferhanoglu's
- Fellowship, 1988, Istanbul University, Istanbul
- Graduation, 1978, Istanbul University, Istanbul
• Second rank award in Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006 • Best abstract award in “4th Aegean Hematology-Oncology Symposium”, Rhodes, Greece, September 21-24, 2017 • Roche Non-Hodgkin Lymphoma” award. (Turkish Society of Hematology Roche Industry Award) in the Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006. • “TSH Clinical Laboratory Hematology” award in Turkish Society of Hematology 30th National Hematology Congress, İstanbul, 2003.
Book chapters:
- Ferhanoglu B, Ozbalak M. Diffüz Büyük B Hücreli Lenfoma (Article published in Turkish, Title: Diffuse Large B Cell Lymphoma). Ed. Teoman Soysal HematoLog-Special Issue on Lymphoma. 2013; 3(2): 355-81.
- Ferhanoglu B, Ozbalak M. Primer Merkezi Sinir Sistemi Lenfomaları (Article published in Turkish, Title: Primary Central Nervous System Lymphomas). Ed. Teoman Soysal HematoLogSpecial Issue on Lymphoma. 2013; 3(2): 382-94.
- Burhan Ferhanoğlu, “Anemia: Definition-Classification, Hematology Course Book” University Issue Nr.: 4774, Cerrahpaşa School of Medicine Issue Nr.: 269, ISBN: 978-975- 404-815-5, page: 21-26, 2008.
Articles Published in International Journals:
- Ozyigit LP, Aktas EC, Senbas ZA, Ozturk AB, Ozturk E, Ergonul MO, Tabak L, Ferhanoglu B, Cetiner M, Deniz G. The role of atopy in the pathogenesis of bleomycin pulmonary toxicity. Respiratory medicine. 2019; 155: 1-5.
- Younes A, Brody J, Carpio C, Lopez-Guillermo A, Ben-Yehuda D, Ferhanoglu B, Nagler A, Ozcan M, Avivi I, Bosch F, Caballero Barrington MD, Hellmann A, Kuss B, Ma DDF, Demirkan F, Yagci M, Horowitz NA, Marlton P, Cordoba R, Wrobel T, Buglio D, Streit M, Hodkinson BP, Schaffer M, Alvarez J, Ceulemans R, Balasubramanian S, de Jong J, Wang SS, Fourneau N, Jurczak W. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed nonHodgkin lymphoma or chronic lymphocytic leukemia: a phase 1/2a study. The Lancet Haematology. 2019; 6(2): e67-e78
- Ferhanoglu B, Ozturk E, Ozbalak M. Venetoclax-Rituximab in Chronic Lymphocytic Leukemia. The New England journal of medicine. 2018; 378(22): 2141-2.
- Ozturk E, Akay MO, Ferhanoglu B. Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis. Turk J Haematol. 2018; 35(3): 208-9.
International Conference Presentations:
- Ferhanoğlu B, Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Özbalak M; “Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience” Poster Session in 4th Aegean Hematology-Oncology Symposium”, Rhodes, Greece, September 21-24, 2017
- Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S Catal Tatonyan S, Ongoren Aydin S, Ar MC, Baslar Z, Sayitoglu M, Ferhanoglu B, Aydin Y, Ozbek U, Soysal T Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. 53rd ASH Annual Meeting and Exposition, Oral Session, Abstract No:384, December 7-10, 2013, Louisiana, New Orleans, USA.
- Murat OZBALAK, Ilyas Tokatlı, Metin Özdemirli, Tulay Tecimer, M. Cem Ar, Serdar Örnek, Aykut Koroglu, Yahya Laleli & Burhan Ferhanoglu. 2013b. IS VALGANCICLOVIR REALLY EFFECTIVE IN PRIMARY EFFUSION LYMPHOMA?: CASE REPORT OF AN HIV(-) EBV(-) HHV8(+) PATIENT. Poster Presentation: In 4th International Congress of Leukemia-Lymphoma-Myeloma. Istanbul, Turkey
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Dr. Burhan Ferhanoglu in Istanbul
Hematologist
Senior Consultant
Graduation,Post Graduation
Istanbul, Turkey
35 years of experience
Hematologist
Senior Consultant
Graduation
Istanbul, Turkey
32 years of experience
Hematologist
Associate Professor
Diplomate,Graduation,Post Graduation
Istanbul, Turkey
24 years of experience
Hematologist
Professor
Graduation,Post Graduation
Istanbul, Turkey
29 years of experience
Hematologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
11 years of experience
Hematologist
Professor
Fellowship,Graduation
Istanbul, Turkey
15 years of experience
Istinye University Medical Park Gaziosmanpasa Hospital, Turkey
Hematologist
Associate Professor
Fellowship,Graduation
Istanbul, Turkey
13 years of experience
